Miguel-Angel Perales on Graft Versus Host Disease

Video

Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center, discusses graft versus host disease (GVHD) after a bone marrow transplant.

Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center, discusses graft versus host disease (GVHD) after a bone marrow transplant.

A bone marrow transplant remains a critical treatment approach for patients with acute leukemia and myelodysplastic syndromes, but can be associated with complications such as GVHD.

GVHD happens when the donor's

white blood cells (T cells) attack the patient’s organs, which can cause many problems, Perales says.

A national phase III study being run by the Blood and Marrow Transplant Clinical Trials Network is evaluating GVHD relapse-free survival in patients 1 year after transplant to hopefully reduce complications from transplant.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
2 experts are featured in this series.
Image of a woman with shoulder-length black hair wearing headphones and a white sweater
Related Content
Oncology Nurses Provide Patients an Avenue to Supportive Care

Oncology Nurses Provide Patients an Avenue to Supportive Care

Diana Martins-Welch, MD
November 12th 2019
Article

Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.

New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

Daniel J. George, MD
October 3rd 2019
Article

For patients with advanced prostate cancer, new findings from the CARD trial could change their daily treatment.

Adverse Events of CAR T-Cell Therapy

Adverse Events of CAR T-Cell Therapy

Sattva S. Neelapu, MD
July 28th 2019
Article

It is crucial for nurses to be aware of adverse events that can occur in patients who are receiving CAR T-cell therapy, explained one expert.

Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

MaryBeth Freeman, MPH
May 8th 2019
Article

After the USPSTF advised against prostate cancer screening for all men, there was a decrease in the incidence of the disease.

Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

Hyman B. Muss, MD
March 23rd 2016
Article

Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.

Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

Kimberly J. Van Zee, MS, MD, FACS
March 18th 2016
Article

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).